US 6,541,043 B2 · Method and synergistic composition for treating attention deficit/hyperactivity disorder

Abstract

A composition and method for treating Attention Deficit/Hyperactivity Disorder (ADHD) is provided which can be used both with and without ethical drugs now used to treat ADHD. The composition contains dimethylaminoethanol (DMAE), omega 3-fatty acids, betaine, oligomeric proanthocyanidins (OPC), folic acid, vitamins C, E, B12, B6, B5 and beta-carotene and minerals (calcium, magnesium, zinc and selenium). Ethical drugs such as amphetamines, methylphenidate HCl and pemoline are known to control ADHD, but each has significant side effects when used in their therapeutic dose. When combining the composition with such ethical drugs, the amount of the ethical drug can be lowered below a level which causes undesirable side effects which is an important feature. Preferred compositions contain one or more of lecithin, choline, 5-hydroxytryptophan, tyrosine, Reishi Extract, Kava Extract, Gingko, Ginseng and St. John's Wort.

Claims20

Dependent claims

A composition for treating Attention Deficit/Hyperactivity Disorder consisting essentially of:

dimethylaminoethanol;
omega-3 fatty acid;
betaine;
Vitamins A, B5, B6, B12, C and E;
folic acid;
minerals including calcium, magnesium, zinc and selenium;
and
oligomeric proanthocyanidins.

5 more elements

Dependencies are inferred from the claim text.

Facts

Application

09/941,422Filed 28 Aug 2001

Published

US 2003/0044472 A16 Mar 2003

Granted

1 Apr 2003

Term ends

Not estimatedThe source records don’t support an estimate.

Classification17 codes

A61K 33/02
Medicinal preparations containing inorganic active ingredients: ammonia; Compounds thereof
A61K 31/07
Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates: retinol compounds, e.g. vitamin A
A61K 31/133
Amines: having hydroxy groups, e.g. sphingosine
A61K 31/20
Carboxylic acids, e.g. valproic acid: having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids

Method and synergistic composition for treating attention deficit/hyperactivity disorder

Life of this patent

Method and synergistic composition for treating attention deficit/hyperactivity disorder

Life of this patent

Abstract

Claims20